NOSAÏS
NOSAÏS, established in 2020, is a French non-profit organisation dedicated to scientific research on biomedical detection dogs and the benefits they bring to the human medical industry.
Dogs have an incredible olfactory sense and memory, providing them the ability to detect a non-exhaustive list of diseases, opening up an exciting and ongoing topic of conversation.
NOSAÏS began in France, then expanded to the UAE through collaboration with the Ministry of Interior and Dubai Police, experiencing resounding success with their dogs accurate detection of the Covid-19 virus during the pandemic from sweat samples and undertaking trainings on breath samples from used face masks to further increase the sensitivity and specificity of this detection in the following years.
Since then, with the support from SV Companies, NOSAÏS detection dogs were able to further impact the medical industry through their ability to demonstrate early detection of high grade prostate cancers (Gleason 6+ for specialists). This has allowed NOSAÏS to drive forward with their team, implementing new protocols for several different samples:
Parkinson disease (from neck sweat)
Melanomas (with a new approach for dog imprinting)
Bladder cancers (from urine)
Charcot disease (starting soon)
Glioblastomas (brain cancers affecting children and very hard to detect)
The dogs working with the NOSAÏS team are all family dogs, who are taught this life changing method of human disease detection as play, keeping them motivated and focused. The NOSAÏS training principles are designed so that when the dog independently locates the affected sample, they are rewarded with food or toy – this is known as positive reinforcement. The dogs are also trained to inform the team when no positive result is detected in a sample line and even to show the team that they want a little break!
Right now the integral work is conducted at Alfort National School of Veterinary Medicine (close to Paris), with the NOSAÏS Institute being opened in the near future in a region north of Paris (Oise).
The team hopes that within a few years of proving the efficacy of this alternative scientific approach, it can convince health administrations to allow trained family dogs to enter early detection programs for both chronic (proliferative or degenerative) diseases, but also in cases of an eventual new viral pandemic.
SV TALKS PODCAST
In this exclusive episode of SV Talks, Prof. Dominique Grandjean dives into the groundbreaking work of NOSAÏS, a world-leading initiative in medical scent detection using trained dogs. Discover how specially trained dogs are detecting diseases like COVID-19, colon cancer, and Parkinson's through canine olfaction—and how NOSAÏS is revolutionizing global healthcare with this powerful, non-invasive detection method.
Watch and learn how research, training, and validation come together to support medical innovation.